Company Overview of Genetic Immunity, LLC
Genetic Immunity, LLC, a biotechnology company, engages in the development of nano-medicine based therapeutic vaccines against infectious diseases, cancer, allergy, AIDS, and other chronic conditions. Its products include DermaVir, a therapeutic vaccine candidate for the treatment of HIV/AIDS; Intracellular Bacteria, a chlamyderm vaccine against Chlamydia infections; DermAll, a vaccine against dust mite allergen; and DermaPrep, a transdermal delivery system. Genetic Immunity, LLC was founded in 1998 and is based in McLean, Virginia with business, medical, and legal operations in the United States; and research facilities in Hungary and Italy. As of September 28, 2012, Genetic Immunity, LLC o...
8300 Greensboro Drive
McLean, VA 22102
Founded in 1998
Key Executives for Genetic Immunity, LLC
Chief Financial officer and Treasurer
Chief Operating officer and Vice President of Operations
Director of Finance & Administration
Compensation as of Fiscal Year 2014.
Genetic Immunity, LLC Key Developments
Genetic Immunity, LLC Announces Executive Appointments
Jun 11 13
Julianna Lisziewicz, Ph.D. has been appointed as Chief Science Officer of Genetic Immunity, LLC. In addition, Franco Lori, M.D. will no longer serve as a member of the Board. On May 31, 2013, the Board unanimously approved the appointment of Peter Boros as a member of the Board. Mr. Peter Boros currently serves as Chief Executive Officer of iGlue Inc. where he is responsible for the day to day operations of the company. Since July 1, 2007, Mr. Boros has served as the Commercial Director of Co-Op Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries